Cargando…

Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia

Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy caused by mutations in genes encoding transcriptional and epigenetic regulators together with signaling genes. It is characterized by a disturbance of differentiation and abnormal proliferation of hematopoietic progenitors. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamo, Assunta, Chin, Paulynn, Keane, Peter, Assi, Salam A., Potluri, Sandeep, Kellaway, Sophie G., Coleman, Daniel, Ames, Luke, Ptasinska, Anetta, Delwel, H. Ruud, Cockerill, Peter N., Bonifer, Constanze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883165/ https://www.ncbi.nlm.nih.gov/pubmed/36333583 http://dx.doi.org/10.1038/s41375-022-01744-5

Ejemplares similares

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction
por: Ptasinska, Anetta, et al.
Publicado: (2019)

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction
por: Ptasinska, Anetta, et al.
Publicado: (2019)

Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth
por: Coleman, Daniel J.L., et al.
Publicado: (2023)

RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
por: Loke, Justin, et al.
Publicado: (2017)

t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming
por: Kellaway, Sophie, et al.
Publicado: (2020)

Subtype-specific regulatory network rewiring in acute myeloid leukemia
por: Assi, Salam A., et al.
Publicado: (2018)

Different mutant RUNX1 oncoproteins program alternate haematopoietic differentiation trajectories
por: Kellaway, Sophie G, et al.
Publicado: (2021)

Rewiring of the Transcription Factor Network in Acute Myeloid Leukemia
por: Assi, Salam A, et al.
Publicado: (2019)

RUNX1-EVI1 disrupts lineage determination and the cell cycle by interfering with RUNX1 and EVI1 driven gene regulatory networks
por: Kellaway, Sophie G., et al.
Publicado: (2020)

Chronic growth factor receptor signaling and lineage inappropriate gene expression in AML: The polycomb connection
por: Ray, Debleena, et al.
Publicado: (2013)

Modelling t(8;21) acute myeloid leukaemia ‐ What have we learned?
por: Chin, Paulynn Suyin, et al.
Publicado: (2020)

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
por: Martinez-Soria, Natalia, et al.
Publicado: (2018)

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
por: Martinez-Soria, Natalia, et al.
Publicado: (2019)

Wellington-bootstrap: differential DNase-seq footprinting identifies cell-type determining transcription factors
por: Piper, Jason, et al.
Publicado: (2015)

Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
por: Avellino, Roberto, et al.
Publicado: (2022)

A genome-wide relay of signalling-responsive enhancers drives hematopoietic specification
por: Edginton-White, B., et al.
Publicado: (2023)

Identification of a Dynamic Core Transcriptional Network in t(8;21) AML that Regulates Differentiation Block and Self-Renewal
por: Ptasinska, Anetta, et al.
Publicado: (2014)

Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma
por: Edginton-White, Benjamin, et al.
Publicado: (2018)

Chromatin priming elements direct tissue-specific gene activity before hematopoietic specification
por: Maytum, Alexander, et al.
Publicado: (2023)

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
por: Pabst, T, et al.
Publicado: (2009)

Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature
por: Cauchy, Pierre, et al.
Publicado: (2015)

Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’
por: Hou, H-A, et al.
Publicado: (2009)

Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis
por: Quintana-Bustamante, Oscar, et al.
Publicado: (2012)

Developmental-stage-dependent transcriptional response to leukaemic oncogene expression
por: Regha, Kakkad, et al.
Publicado: (2015)

The Co-operation of RUNX1 with LDB1, CDK9 and BRD4 Drives Transcription Factor Complex Relocation During Haematopoietic Specification
por: Gilmour, Jane, et al.
Publicado: (2018)

Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
por: Jakobsen, Janus S., et al.
Publicado: (2019)

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report
por: Helbig, Grzegorz, et al.
Publicado: (2014)

The ASXL1-G643Wvariant accelerates the development of CEBPA mutant acute myeloid leukemia
por: D’Altri, Teresa, et al.
Publicado: (2020)

Cooperative binding of AP-1 and TEAD4 modulates the balance between vascular smooth muscle and hemogenic cell fate
por: Obier, Nadine, et al.
Publicado: (2016)

The LPS-Induced Transcriptional Upregulation of the Chicken Lysozyme Locus Involves CTCF Eviction and Noncoding RNA Transcription
por: Lefevre, Pascal, et al.
Publicado: (2008)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2019)

TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
por: Heyes, Elizabeth, et al.
Publicado: (2023)

Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis of CEBPA mutant acute myeloid leukemia
por: Chen, Xinjie, et al.
Publicado: (2023)

Expression of RUNX1-ETO Rapidly Alters the Chromatin Landscape and Growth of Early Human Myeloid Precursor Cells
por: Nafria, Monica, et al.
Publicado: (2020)

HoxA9 binds and represses the Cebpa +8 kb enhancer
por: Peng, Lei, et al.
Publicado: (2019)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
por: Yuan, Ji, et al.
Publicado: (2023)

RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1
por: Ponnusamy, K, et al.
Publicado: (2015)

Wellington: a novel method for the accurate identification of digital genomic footprints from DNase-seq data
por: Piper, Jason, et al.
Publicado: (2014)

Wellington: a novel method for the accurate identification of digital genomic footprints from DNase-seq data
por: Piper, Jason, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8d43l7t03h21lqd13krvvbn9eh